Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*.
Critical Care Medicine · 2012-09-14 · Meta-analysis
Abstract
OBJECTIVE: To evaluate the effects of single-dose etomidate on the adrenal axis and mortality in patients with severe sepsis and septic shock. DESIGN: A systematic review of randomized controlled trials and observational studies with meta-analysis. SETTING: Literature search of EMBASE, Medline, Cochrane Database, and Evidence-Based Medical Reviews. SUBJECTS: Sepsis patients who received etomidate for rapid sequence intubation. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We conducted a systematic review of randomized controlled trials and observational studies with meta-analysis assessing the effects of etomidate on adrenal insufficiency and all-cause mortality published between January 1950 and February 2012. We only examined studies including septic patients. All-cause mortality served as our primary end point, whereas the prevalence of adrenal insufficiency was our secondary end point. Adrenal insufficiency was determined using a cosyntropin stimulation test in all studies. We used a random effects model for analysis; heterogeneity was assessed with the I statistic. Publication bias was evaluated with Begg's test. Five studies were identified that assessed mortality in those who received etomidate. A total of 865 subjects were included. Subjects who received etomidate were more likely to die (pooled relative risk 1.20; 95% confidence interval 1.02-1.42; Q statistic, 4.20; I2 statistic, 4.9%). Seven studies addressed the development of adrenal suppression associated with the administration of etomidate; 1,303 subjects were included. Etomidate administration increased the likelihood of developing adrenal insufficiency (pooled relative risk 1.33; 95% confidence interval 1.22-1.46; Q statistic, 10.7; I2 statistic, 43.9%). CONCLUSIONS: Administration of etomidate for rapid sequence intubation is associated with higher rates of adrenal insufficiency and mortality in patients with sepsis.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Anaesthetics · Etomidate · Endotracheal intubation · Mortality & survival · Rapid sequence intubation
Related articles
- Outcomes of Sedative Hypnotic Agents Used for Endotracheal Intubation in Critically Ill Adults: A Systematic Review with Exploratory Meta-Analysis. (J Intensive Care Med, 2026)
- Ketamine versus etomidate as an induction agent for tracheal intubation in critically ill adults: a Bayesian meta-analysis. (Crit Care, 2024)
- Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients. (Cochrane Database Syst Rev, 2015)
- Anesthetic induction drugs during tracheal intubation in critically ill patients: a systematic review. (J Anesth, 2026)
- Ketamine versus Etomidate as an induction agent for tracheal intubation: An updated meta-analysis of randomized clinical trials. (Anaesth Crit Care Pain Med, 2026)
- Induction agents for emergency tracheal intubation in critically ill adults: a systematic review and network meta-analysis. (Crit Care, 2026)